1. Home
  2. ATAI vs GHI Comparison

ATAI vs GHI Comparison

Compare ATAI & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • GHI
  • Stock Information
  • Founded
  • ATAI 2018
  • GHI 1998
  • Country
  • ATAI Germany
  • GHI United States
  • Employees
  • ATAI N/A
  • GHI N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • GHI Finance: Consumer Services
  • Sector
  • ATAI Health Care
  • GHI Finance
  • Exchange
  • ATAI Nasdaq
  • GHI Nasdaq
  • Market Cap
  • ATAI 271.6M
  • GHI 285.3M
  • IPO Year
  • ATAI 2021
  • GHI N/A
  • Fundamental
  • Price
  • ATAI $1.52
  • GHI $12.93
  • Analyst Decision
  • ATAI Strong Buy
  • GHI Strong Buy
  • Analyst Count
  • ATAI 4
  • GHI 3
  • Target Price
  • ATAI $9.00
  • GHI $16.50
  • AVG Volume (30 Days)
  • ATAI 1.8M
  • GHI 44.6K
  • Earning Date
  • ATAI 03-17-2025
  • GHI 05-07-2025
  • Dividend Yield
  • ATAI N/A
  • GHI 11.45%
  • EPS Growth
  • ATAI N/A
  • GHI N/A
  • EPS
  • ATAI N/A
  • GHI 0.76
  • Revenue
  • ATAI $308,000.00
  • GHI $32,275,700.00
  • Revenue This Year
  • ATAI N/A
  • GHI $226.38
  • Revenue Next Year
  • ATAI $20.00
  • GHI N/A
  • P/E Ratio
  • ATAI N/A
  • GHI $17.01
  • Revenue Growth
  • ATAI N/A
  • GHI N/A
  • 52 Week Low
  • ATAI $0.78
  • GHI $10.12
  • 52 Week High
  • ATAI $2.85
  • GHI $16.82
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 50.35
  • GHI 55.57
  • Support Level
  • ATAI $1.37
  • GHI $12.78
  • Resistance Level
  • ATAI $1.48
  • GHI $13.29
  • Average True Range (ATR)
  • ATAI 0.10
  • GHI 0.35
  • MACD
  • ATAI 0.02
  • GHI -0.01
  • Stochastic Oscillator
  • ATAI 79.71
  • GHI 55.00

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.

Share on Social Networks: